These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8393159)

  • 41. p53 Specifically Binds Triplex DNA In Vitro and in Cells.
    Brázdová M; Tichý V; Helma R; Bažantová P; Polášková A; Krejčí A; Petr M; Navrátilová L; Tichá O; Nejedlý K; Bennink ML; Subramaniam V; Bábková Z; Martínek T; Lexa M; Adámik M
    PLoS One; 2016; 11(12):e0167439. PubMed ID: 27907175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53-dependent activation of the mouse MCK gene promoter: identification of a novel p53-responsive sequence and evidence for cooperation between distinct p53 binding sites.
    Jackson P; Shield M; Buskin J; Hawkes S; Reed M; Perrem K; Hauschka SD; Braithwaite A
    Gene Expr; 1995; 5(1):19-33. PubMed ID: 7488858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 oligomerization and DNA looping are linked with transcriptional activation.
    Stenger JE; Tegtmeyer P; Mayr GA; Reed M; Wang Y; Wang P; Hough PV; Mastrangelo IA
    EMBO J; 1994 Dec; 13(24):6011-20. PubMed ID: 7813439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Advances in the research on anti-oncogenes P53].
    Li JY; Tong TJ
    Sheng Li Ke Xue Jin Zhan; 1993 Apr; 24(2):137-8. PubMed ID: 8211064
    [No Abstract]   [Full Text] [Related]  

  • 45. A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat.
    Gualberto A; Hixon ML; Finco TS; Perkins ND; Nabel GJ; Baldwin AS
    Mol Cell Biol; 1995 Jun; 15(6):3450-9. PubMed ID: 7760842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A transcriptionally active DNA-binding site for human p53 protein complexes.
    Funk WD; Pak DT; Karas RH; Wright WE; Shay JW
    Mol Cell Biol; 1992 Jun; 12(6):2866-71. PubMed ID: 1588974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discrimination of DNA binding sites by mutant p53 proteins.
    Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
    Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.
    Menendez D; Inga A; Resnick MA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1500-5. PubMed ID: 20080630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirement of clathrin heavy chain for p53-mediated transcription.
    Enari M; Ohmori K; Kitabayashi I; Taya Y
    Genes Dev; 2006 May; 20(9):1087-99. PubMed ID: 16618797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA-mediated oxidation of p53.
    Schaefer KN; Barton JK
    Biochemistry; 2014 Jun; 53(21):3467-75. PubMed ID: 24853816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-level p53 expression changes transactivation rules and reveals superactivating sequences.
    Jordan JJ; Menendez D; Sharav J; Beno I; Rosenthal K; Resnick MA; Haran TE
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14387-92. PubMed ID: 22908277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional activation analysis of oncogene function.
    Hauser CA; Der CJ; Cox AD
    Methods Enzymol; 1994; 238():271-6. PubMed ID: 7799793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional regulation by p53. Functional interactions among multiple regulatory domains.
    Hsu YS; Tang FM; Liu WL; Chuang JY; Lai MY; Lin YS
    J Biol Chem; 1995 Mar; 270(12):6966-74. PubMed ID: 7896847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding of wild-type and mutant forms of p53 protein from human tumors to a specific DNA-sequence of the first intron of the h-ras oncogene.
    Zoumpourlis V; Zachos G; Halazonetis T; Ergazaki M; Spandidos D
    Int J Oncol; 1995 Nov; 7(5):1035-41. PubMed ID: 21552928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 tagged sites from human genomic DNA.
    Tokino T; Thiagalingam S; el-Deiry WS; Waldman T; Kinzler KW; Vogelstein B
    Hum Mol Genet; 1994 Sep; 3(9):1537-42. PubMed ID: 7833908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of p53 as a sequence-specific DNA-binding protein.
    Kern SE; Kinzler KW; Bruskin A; Jarosz D; Friedman P; Prives C; Vogelstein B
    Science; 1991 Jun; 252(5013):1708-11. PubMed ID: 2047879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atomic force microscopy reveals kinks in the p53 response element DNA.
    Balagurumoorthy P; Lindsay SM; Harrington RE
    Biophys Chem; 2002 Dec; 101-102():611-23. PubMed ID: 12488030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of IL6 gene expression.
    Sehgal PB
    Res Immunol; 1992 Sep; 143(7):724-34. PubMed ID: 1439145
    [No Abstract]   [Full Text] [Related]  

  • 59. Cellular and molecular advances in elucidating p53 function.
    Shay JW; Werbin H; Funk WD; Wright WE
    Mutat Res; 1992 Aug; 277(2):163-71. PubMed ID: 1378532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transactivation of TauT by p53 in MCF-7 cells: the role of estrogen receptors.
    Han X; Patters AB; Chesney RW
    Adv Exp Med Biol; 2003; 526():139-47. PubMed ID: 12908594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.